DB
Deepak Bahri
About Deepak Bahri
Data last updated:
Deepak Bahri is a Managing Director at Sentiss Pharma Private Limited (since 1995), Partner at Multiples Private Equity Fund Ii Llp (since 2015) and Director at Pulse Pharma Private Limited (since 1995), and holds 1 more current directorship. The companies operate in Healthcare and Financial Services. The 4 current companies with reported revenue have a combined latest revenue of ₹1,294 Cr; the largest is Sentiss Pharma Private Limited at ₹1,263 Cr (FY 2025). Earlier, Deepak Bahri was a Director at Pulse Medika Private Limited (from 1992).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 01 May 1995 | 1994 | ₹1,263 Cr (FY 2025) | Active | |
| Partner | 30 Jun 2015 | 2015 | ₹31.11 Cr (FY 2025) | Active | |
| Director | 31 Jan 1995 | 1995 | ₹61.2 Lakh (FY 2025) | Active | |
| Director | 23 Jan 1992 | 1992 | ₹2.7 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Mar 1992 | 1992 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Deepak Bahri
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepak Bahri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepak Bahri
Deepak Bahri currently holds 4 directorships: Sentiss Pharma Private Limited (Managing Director, since 01 May 1995, revenue ₹1,263 Cr (FY 2025)); Multiples Private Equity Fund Ii Llp (Partner, since 30 Jun 2015, revenue ₹31.11 Cr (FY 2025)); Pulse Pharma Private Limited (Director, since 31 Jan 1995, revenue ₹61.2 Lakh (FY 2025)); Rubicon Securities Private Limited (Director, since 23 Jan 1992, revenue ₹2.7 Lakh (FY 2025)).
Deepak Bahri was first appointed on 23 Jan 1992 as Director at Rubicon Securities Private Limited. The most recent appointment on record is 30 Jun 2015 at Multiples Private Equity Fund Ii Llp.
The 4 current companies of Deepak Bahri that report revenue have a combined latest revenue of ₹1,294 Cr: Sentiss Pharma Private Limited ₹1,263 Cr (FY 2025); Multiples Private Equity Fund Ii Llp ₹31.11 Cr (FY 2025); Pulse Pharma Private Limited ₹61.2 Lakh (FY 2025); Rubicon Securities Private Limited ₹2.7 Lakh (FY 2025).
Deepak Bahri held 1 earlier board appointment: Pulse Medika Private Limited (Director, from 27 Mar 1992).
The current boards of Deepak Bahri's companies include Canakapalli Bhaktavatasala Rao (Sentiss Pharma Private Limited), Deepak Kumar Khungar (Sentiss Pharma Private Limited), Geeta Mathur (Sentiss Pharma Private Limited), Mahesh Kumar Garg (Sentiss Pharma Private Limited), Sameer Agarwal (Sentiss Pharma Private Limited), Aditya Ghosh (Multiples Private Equity Fund Ii Llp), among others.